Epimorphian compound and its use

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/435 (2006.01) C07D 221/28 (2006.01) C12Q 1/00 (2006.01) G01N 30/02 (2006.01) G01N 30/88 (2006.01)

Patent

CA 2318959

A novel compound N-demethyl-sinomenine, a metabolite of the anti-arthritic alkaloid sinomenine, has been identified and characterized. The compound may be incorporated in a pharmaceutical composition and may be administered to patients for treatment of various disorders, such as rheumatoid arthritis. The novel compound has superior biological activity and water solubility as compared to sinomenine.

On a identifié et caractérisé un nouveau composé, le N-diméthyl-sinoménine, qui est un métabolite de la sinoménine alcaloïdique anti-arthritique. Le composé peut être incorporé dans une composition pharmaceutique et peut être administré à des patients pour traiter diverses pathologies, telles que la polyarthrite rhumatoïde. Le nouveau composé se caractérise par une meilleure activité biologique et une meilleure solubilité dans l'eau que la sinoménine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Epimorphian compound and its use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Epimorphian compound and its use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epimorphian compound and its use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1884896

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.